SEC Filings

Filing date	Description	Form	Filing Group	Issuer	View
View HTML 0000899243-19-025615.pdf 0000899243-19-025615.rtf	Oct 16, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0001193125-19-267356.pdf 0001193125-19-267356.rtf 0001193125-19-267356.xls	Oct 15, 2019	An amendment to a SC 13D filing	SC 13D/A	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-024339.pdf 0000899243-19-024339.rtf	Sep 27, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-023815.pdf 0000899243-19-023815.rtf	Sep 18, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0001193125-19-244853.pdf 0001193125-19-244853.rtf 0001193125-19-244853.xls	Sep 13, 2019	Report of unscheduled material events or corporate event	8-K	Current Reports	Eidos Therapeutics, Inc.
View HTML 0001193125-19-243001.pdf 0001193125-19-243001.rtf 0001193125-19-243001.xls	Sep 11, 2019	Report of unscheduled material events or corporate event	8-K	Current Reports	Eidos Therapeutics, Inc.
View HTML 0000899243-19-022994.pdf 0000899243-19-022994.rtf	Sep 06, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 9999999995-19-002009.pdf 9999999995-19-002009.rtf	Aug 29, 2019	EFFECT	EFFECT	Other	Eidos Therapeutics, Inc.
View HTML 0001193125-19-227896.pdf 0001193125-19-227896.rtf 0001193125-19-227896.xls	Aug 23, 2019	Pre-effective amendment to an S-3 filing	S-3/A	Registration Statements	Eidos Therapeutics, Inc.
View HTML 0000899243-19-022075.pdf 0000899243-19-022075.rtf	Aug 19, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.